EU approves two sites for making Pfizer's COVID-19 vaccine

1 minute read

A vial and sryinge are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration

Register now for FREE unlimited access to Reuters.com

Oct 18 (Reuters) - Europe's drug regulator said on Monday it has approved two more manufacturing sites for producing the COVID-19 vaccine developed by Pfizer Inc (22UAy.DE), while also approving a ready-to-use formulation of the coronavirus shot.

Register now for FREE unlimited access to Reuters.com
Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta

Our Standards: The Thomson Reuters Trust Principles.